Aardal-Eriksson E, Karlberg B E, Holm A C
Department of Biomedicine and Surgery, Faculty of Health Sciences, Linköping University, Sweden.
Clin Chem Lab Med. 1998 Apr;36(4):215-22. doi: 10.1515/CCLM.1998.037.
Salivary cortisol was measured as an alternative to serum cortisol as a marker for adrenocortical function following insulin tolerance test, corticotropin-releasing-hormone stimulation and adreno-corticotrophic hormone stimulation. During insulin tolerance test and corticotropin-releasing-hormone stimulation adreno-corticotrophic hormone was also measured. The tests were performed on healthy control subjects as well as on patients under investigation for various disturbances in the hypothalamic-pituitary-adrenocortical axis (insulin tolerance test: 3 controls on two occasions and 14 patients; corticotropin-releasing-hormone stimulation: 4 controls and 18 patients; adreno-corticotrophic hormone stimulation: 6 controls and 10 patients). Five patients underwent both insulin tolerance test and corticotropin-releasing-hormone stimulation. Using criteria for adequate cortisol response in serum, the patients were classified as good or poor responders. In 42 of the 45 tests performed the same conclusion as to cortisol status was drawn when based on serum and salivary cortisol responses. In healthy subjects and good responders the mean cortisol relative increase was greater in saliva than in serum in all three tests (p < 0.05). Characteristic of the results for the insulin tolerance test was a significant initial mean decrease (p < 0.05), not found in serum, and the highest observed salivary cortisol value was delayed for at least 30 minutes compared to that in serum. Plasma adreno-corticotrophic hormone correlated significantly with the cortisol concentrations determined 15 minutes later in serum (r = 0.54-0.64) and in saliva (r = 0.76-0.85). The more pronounced cortisol response in saliva than in serum and its closer correlation with adreno-corticotrophic hormone offer advantages over serum cortisol, suggesting salivary cortisol measurement may be used as an alternative parameter in dynamic endocrine test.
在胰岛素耐量试验、促肾上腺皮质激素释放激素刺激试验和促肾上腺皮质激素刺激试验后,测量唾液皮质醇作为血清皮质醇的替代指标,以评估肾上腺皮质功能。在胰岛素耐量试验和促肾上腺皮质激素释放激素刺激试验期间,也测量促肾上腺皮质激素。这些试验在健康对照受试者以及因下丘脑-垂体-肾上腺皮质轴各种紊乱而接受调查的患者中进行(胰岛素耐量试验:两次试验中有3名对照者和14名患者;促肾上腺皮质激素释放激素刺激试验:4名对照者和18名患者;促肾上腺皮质激素刺激试验:6名对照者和10名患者)。5名患者同时接受了胰岛素耐量试验和促肾上腺皮质激素释放激素刺激试验。根据血清中皮质醇反应充分的标准,将患者分为反应良好或反应不佳者。在进行的45项试验中的42项中,根据血清和唾液皮质醇反应得出了关于皮质醇状态的相同结论。在所有三项试验中,健康受试者和反应良好者唾液中皮质醇的平均相对增加幅度均大于血清(p<0.05)。胰岛素耐量试验结果的特点是最初有显著的平均下降(p<0.05),血清中未发现这种情况,并且观察到的唾液皮质醇最高值比血清中延迟至少30分钟。血浆促肾上腺皮质激素与15分钟后血清(r=0.54-0.64)和唾液(r=0.76-0.85)中测定的皮质醇浓度显著相关。唾液中皮质醇反应比血清中更明显,且与促肾上腺皮质激素相关性更强,这比血清皮质醇具有优势,表明唾液皮质醇测量可作为动态内分泌试验中的替代参数。